MAPT and Alzheimer disease: Similarly, prion-like properties have also been demonstrated for other neurodegenerative triggers, such as β-amyloid and tau in Alzheimer’s disease, and this behavior may contribute to the transmission and spread of pathology throughout the nervous system (36).